Adam is a health economist with 10 years experience in health economics, health outcomes, pricing and reimbursement. He has held UK and International market access positions for Aventis Pharma and GlaxoSmithKline, respectively. His most recent pharmaceutical industry role was as European Health Outcomes Director at Baxter Healthcare.